Wu Feifei, Bartoletti Viola, Trojan Diletta, Montagner Giulia, Del Verme Jacopo, Zanata Roberto, Canova Giuseppe, Giordan Enrico
Department of Neuroscience, University of Padua, Padua, Italy.
Department of Neurosurgery, Aulss2 Marca Trevigiana, Treviso, Italy.
J Spine Surg. 2025 Jun 27;11(2):256-268. doi: 10.21037/jss-24-130. Epub 2025 Apr 28.
There has been a global increase in spinal fusion surgeries, driving the need for improved graft materials. Human structural allografts from tissue banks provide a safe, cost-effective and efficient alternative, circumventing donor site issues and reducing operating time. This study retrospectively analyses the long-term follow-up of human structural grafts used in various spinal fusion surgeries. The analysis aims to highlight that structural bone grafts are a viable option for spinal fusion.
The study included 147 patients over 18 years old who were treated for cervical and lumbar spinal degenerative, traumatic or oncologic conditions at a single hospital from January 2006 to December 2016. Clinical and radiological follow-up was conducted until December 2023. Human structural bone grafts, sourced from cadaver donors and provided by a single tissue bank, were used in all cases.
A total of 98 patients underwent cervical surgery. Among these, 77.6% received bone grafting due to cervical spine fracture luxation, 21.4% for severe degenerative conditions, and 1.0% for corpectomy consequent to tumour metastasis. The mean follow-up was 155.0±35.7 months, with no subsidence documented. A total of 49 patients underwent lumbar surgery, with 95.9% receiving human bone grafting for lumbar spine fracture luxation and the remaining patients for multiple myeloma and degenerative conditions. The mean overall follow-up was 144.7±38.9 months, with only 1 case of subsidence registered in this group. In 98.9% of cervical and 97.9% of lumbar patients, satisfactory fusion was achieved and maintained over the years.
Homologous structural bone grafting remains an excellent option for spinal fusion in traumatic and degenerative conditions or as a valuable option in spinal revision surgeries and in cases where the use of cages is not feasible due to anatomical constraints.
全球脊柱融合手术数量不断增加,这促使人们需要改进移植材料。组织库提供的人类结构性同种异体移植物是一种安全、经济高效的替代选择,可避免供体部位问题并减少手术时间。本研究回顾性分析了各种脊柱融合手术中使用的人类结构性移植物的长期随访情况。该分析旨在强调结构性骨移植是脊柱融合的可行选择。
本研究纳入了147例18岁以上患者,他们于2006年1月至2016年12月在一家医院接受了颈椎和腰椎脊柱退行性、创伤性或肿瘤性疾病的治疗。临床和影像学随访持续至2023年12月。所有病例均使用了来自尸体供体并由单一组织库提供的人类结构性骨移植。
共有98例患者接受了颈椎手术。其中,77.6%因颈椎骨折脱位接受骨移植,21.4%因严重退行性疾病接受骨移植,1.0%因肿瘤转移行椎体切除术接受骨移植。平均随访时间为155.0±35.7个月,未记录到下沉情况。共有49例患者接受了腰椎手术,95.9%因腰椎骨折脱位接受人类骨移植,其余患者因多发性骨髓瘤和退行性疾病接受骨移植。总体平均随访时间为144.7±38.9个月,该组仅记录到1例下沉情况。在98.9%的颈椎患者和97.9%的腰椎患者中,多年来均实现并维持了满意的融合。
同种异体结构性骨移植仍然是创伤性和退行性疾病脊柱融合的极佳选择,或者是脊柱翻修手术以及由于解剖限制无法使用椎间融合器的情况下的宝贵选择。